Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Accumulated Expenses (2025)

Cannabis Bioscience International Holdings' Accumulated Expenses history spans 1 years, with the latest figure at $26773.0 for Q4 2025.

  • For Q4 2025, Accumulated Expenses changed N/A year-over-year to $26773.0; the TTM value through Nov 2025 reached $26773.0, changed N/A, while the annual FY2025 figure was $22095.0, N/A changed from the prior year.
  • Accumulated Expenses for Q4 2025 was $26773.0 at Cannabis Bioscience International Holdings, up from $22095.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $26773.0 in Q4 2025 and bottomed at $22095.0 in Q2 2025.